| ORIGINAL ARTICLE |
|
| Year : 2014 | Volume
: 10
| Issue : 38 | Page : 306-310 |
|
|
Luteolin, a bioflavonoid inhibits azoxymethane-induced colon carcinogenesis: Involvement of iNOS and COX-2
Ashok Kumar Pandurangan, Suresh Kumar, Prakash Dharmalingam, Sudhandiran Ganapasam
Department of Biochemistry, University of Madras, Guindy Campus, Chennai, India
Correspondence Address:
Sudhandiran Ganapasam
Department of Biochemistry,University of Madras, Guindy Campus, Chennai - 600 025
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0973-1296.133285
|
|
|
Colon cancer (CRC) is a serious health problem through worldwide. Development of novel drug without side effect for this cancer was crucial. Luteolin (LUT), a bioflavonoid has many beneficial effects such as antioxidant, anti-inflammatory, anti-proliferative properties. Azoxymethane (AOM), a derivative of 1, 2-Dimethyl hydrazine (DMH) was used for the induction of CRC in Balb/C mice. CRC was induced by intraperitoneal injection of AOM to mice at the dose of 15 mg/body kg weight for 3 weeks. Mouse was treated with LUT at the dose of 1.2 mg/body kg weight orally until end of the experiment. The expression of inducible nitric oxide synthase (iNOS) and cyclooxygense (COX)-2 were analyzed by RT-PCR and immunohistochemistry. The expressions of iNOS and COX-2 were increased in the case of AOM induction. Administration of LUT effectively reduced the expressions of iNOS and COX-2. The present study revealed that, LUT suppresses both iNOS and COX-2 expressions and act as an anti-inflammatory role against CRC. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
